SCHEMBL29077239

SCHEMBL29077239

FC(F)(F)Oc1ccc(-c2noc(CCl)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.55
CASP3 P42574 1/20 0.54
MAPT P10636 2/20 0.53
PKM P14618 1/20 0.53
XBP1 P17861 1/20 0.53
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC1 Q13547 1/20 0.46
DPP4 P27487 1/20 0.46
SCN10A Q9Y5Y9 1/20 0.46
TSHR P16473 2/20 0.45
MAPK1 P28482 2/20 0.45
ALOX15 P16050 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ACACB O00763 1/20 0.45
ACACA Q13085 1/20 0.45
SCN5A Q14524 1/20 0.44
NOTUM Q6P988 2/20 0.44
SIRT2 Q8IXJ6 3/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15489417 0.85 ACACB (0.62) S1PR1CASP3MAPTPKMXBP1
SCHEMBL203702 0.85 S1PR1 (0.55) S1PR1CASP3MAPTPKMXBP1
SCHEMBL19835588 0.83 S1PR1 (0.58) S1PR1CASP3MAPTPKMXBP1
SCHEMBL1220782 0.80 SMN1; SMN2 (0.66) S1PR1CASP3MAPTTSHRMAPK1
SCHEMBL2356588 0.80 S1PR1 (0.65) S1PR1CASP3MAPTHDAC2HDAC8
SCHEMBL6327866 0.79 LMNA (0.71) S1PR1MAPTPKMXBP1HDAC2
SCHEMBL28838884 0.79 MAPT (0.58) S1PR1CASP3MAPTHDAC2HDAC8
SCHEMBL2107628 0.78 NPC1 (0.64) S1PR1MAPTHDAC2HDAC8HDAC1
SCHEMBL28018729 0.78 S1PR1 (0.53) S1PR1CASP3MAPTPKMXBP1
SCHEMBL27207676 0.78 TP53 (0.64) CASP3MAPTTSHRMAPK1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF GUIZHOU UNIVERSITY (CN) 2024-09-12 US disclosed
WO-2024174317-A1 N-PHENYLIMINE-CONTAINING DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 贵州大学 2024-08-29 WO disclosed
CN-116731003-A N-phenylimine-containing derivative, and preparation method and application thereof 贵州大学 2023-09-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300932-A1 N-PHENYLIMINE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF PNMT, NNMT, PAH S1PR1 3535/4885CASP3 1102/4885MAPT 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.